Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T01:12:08.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The Publications section now lists the Larkin et al. 2015 publication with an erratum, replacing the earlier entry; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-06T22:48:01.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Locations section updated: added a general 'Locations' grouping and included CA, MA, NY, and TX; removed California/Massachusetts/New York/Texas locations. The footer revision changed to v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.5%
    Check dated 2025-12-23T09:11:15.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2. The previous Revision: v3.3.1 entry has been removed.
    Difference
    0.0%
    Check dated 2025-12-01T17:50:56.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and v3.2.0 was removed on the page, reflecting a minor update to the document metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:52:38.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page. The study details and other content remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T07:16:52.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.